Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -304,742 | -201,309 | -89,289 | 673,725 | 770,248 |
| Depreciation Amortization | -1,531 | -1,231 | -70 | -8,833 | -4,584 |
| Accounts receivable | -920 | -877 | 765 | -1,299 | -308 |
| Accounts payable and accrued liabilities | 2,891 | 1,084 | -2,821 | 6,601 | 7,357 |
| Other Working Capital | -28,452 | -28,221 | -36,505 | -19,768 | 26,493 |
| Other Operating Activity | 55,990 | 41,941 | 16,431 | -1,040,267 | -1,055,880 |
| Operating Cash Flow | $-276,764 | $-188,613 | $-111,489 | $-389,841 | $-256,674 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,196 | -1,641 | -766 | -1,645 | -678 |
| Purchase Of Investment | -480,681 | -305,700 | -174,903 | -1,542,433 | -1,344,107 |
| Sale Of Investment | 780,985 | 508,894 | 288,256 | 1,018,383 | 868,248 |
| Other Investing Activity | -10,000 | -10,000 | 0 | 889,136 | 889,136 |
| Investing Cash Flow | $287,108 | $191,553 | $112,587 | $363,441 | $412,599 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,119 | 1,684 | 1,619 | 14,442 | 9,600 |
| Financing Cash Flow | $6,119 | $1,684 | $1,619 | $14,442 | $9,600 |
| Beginning Cash Position | 76,247 | 76,247 | 76,247 | 88,205 | 88,205 |
| End Cash Position | 92,710 | 80,871 | 78,964 | 76,247 | 253,730 |
| Net Cash Flow | $16,463 | $4,624 | $2,717 | $-11,958 | $165,525 |
| Free Cash Flow | |||||
| Operating Cash Flow | -276,764 | -188,613 | -111,489 | -389,841 | -256,674 |
| Capital Expenditure | -3,196 | -1,641 | -766 | -1,685 | -718 |
| Free Cash Flow | -279,960 | -190,254 | -112,255 | -391,526 | -257,392 |